Selvaraja Elumalai - distinguished quality control professionals with an experience of more than twenty years in the ...

Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai ...

Pharmaceutical warehousing is not just about storing products; it’s a critical part of the supply chain that ensures the ...

Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.

The exercise is aimed at reducing legal entities and simplify operating structure, said Granules Pharma, and the plan is expected to reduce the number of legal entities, simplify operational ...

Kneat's SaaS model automates validation processes in pharma and biotech, reducing errors and ensuring compliance. Learn why ...

RAY pharmaceutical company from North India approached DSD consultants in Bombay (Mumbai) and requested them to identify a general manager for their Africa operations.

Farther Finance Advisors LLC decreased its holdings in shares of GSK plc (NYSE:GSK – Free Report) by 27.4% during the fourth ...

NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it has promoted Warren Stone, ...

New Lynx FacTOR software-as-a-service solution is designed to minimize manual processes and accelerate release cycles in the ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

Pharmaceutical data management has undergone a significant transformation in recent years, driven by the need for efficiency, ...